About Faridan
Faridan is a venture capital firm founded in 2016. It is primarily based out of New York City, United States. As of Aug 2017, Faridan has invested in 7 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Food and Agriculture Tech. Most recently it participated in the $***** Series A round of Arbor Biotechnologies Overall, Faridan portfolio has seen 2 acquisitions, namely Vicarious and SolveBio. A lot of funds co-invest with Faridan, with names like Acks sharing a substantial percentage of its portfolio. Faridan has team of 1 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A
Portfolio Soonicorns
Faridan's List of Top Investments
Faridan has a portfolio of 7 companies. Their most notable investments include Human Longevity and Arbor Biotechnologies.Their portfolio spans across and United States. They have invested in Enterprise Applications, High Tech, Food and Agriculture Tech and 4 other sectors, across stages such as Series A stage. Here is the list of top investments by Faridan:
Provider of precision medicine, preventative health assessments, and longevity care. The company offers comprehensive health assessments to detect life-threatening conditions early. It focuses on data-driven, personalized healthcare designed to uncover health risks. The company provides services to help individuals take control of their health.
Key facts about Human Longevity
Provider of genomic technologies and drug discovery platform. This platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening for enabling the discovery of proteins. The company has also identified a new CRISPR enzyme using its discovery platform.
Key facts about Arbor Biotechnologies
- Founded Year: 2016
- Location: Cambridge (United States)
- Stage: Series C
- Total Funding till date: $304M
- Employee Count: 102 as on Aug 31, 2026
- Investors: T. Rowe Price, ArrowMark Partners and 27 Others
- Latest Funding Round: Series C, Oct 30, 2025, $*****
- Highlight: Editors' Pick
3. Vicarious
Developer of AI-based robotic arms. It offers solutions for kitting, palletizing, packaging, and wall picking. It also offers robots-as-a-service.
Key facts about Vicarious
- Founded Year: 2010
- Location: San Francisco (United States)
- Stage: Acquired
- Total Funding till date: $250M
- Employee Count: 114 as on Aug 31, 2026
- Investors: AME Cloud Ventures, Pegasus Tech Ventures and 50 Others
- Latest Funding Round: Series D, Jul 25, 2017, $*****
- Highlight: Acquired
Cloud-based remote laboratory automation software for the life sciences industry. The laboratory can be accessed remotely via the Internet where automated robotics conduct experiments, method design, materials logistics, sample preparation, instrument operation, data acquisition and analysis, troubleshooting, waste disposal, and others.
Key facts about Emerald Therapeutics
- Founded Year: 2010
- Location: San Francisco (United States)
- Stage: Series C
- Total Funding till date: $39.5M
- Employee Count: 204 as on Aug 31, 2026
- Investors: Western Technology Investment, VII Ventures and 12 Others
- Latest Funding Round: Series C, Jun 2015, $*****
- Highlight: Editors' Pick
5. SolveBio
The company provides advanced precision medicine data analytics across the therapeutic development life cycle. The company provides frictionless access to complex molecular data and allows translational and clinical teams to seamlessly leverage the latest analytic tools, machine learning algorithms, and big data computational platforms.
Key facts about SolveBio
- Founded Year: 2013
- Location: New York City (United States)
- Stage: Acquired
- Total Funding till date: $2M
- Employee Count: 10 as on Jul 01, 2024
- Investors: Healthy Ventures, Faridan and 9 Others
- Latest Funding Round: Grant (prize money), Jan 08, 2018, $*****
- Highlight: Acquired
Faridan's Year-on-Year Investment Trends
Its most recent first time investment was in Arbor Biotechnologies.Faridan's Investments by Stage
Faridan has made 1 investment in Series A stage with an average round size of $15.6M.Faridan's Investments by Sector
Faridan has a diverse portfolio, with companies operating in the High Tech and Life Sciences. Notably, it has invested in 7 Enterprise (B2B) companies, 6 Tech companies, 4 Software companies and at least 3 companies focusing on Saas.Faridan's Investments by Geography
Faridan has made most investments in United States (1).Faridan's recent investments
Faridan has not made any investment in 2026 so far.Here are the most recent investments by Faridan:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Aug 02, 2017 | United States | Series A | 9427 | [+2] |
Acquired companies in Faridan's Portfolio
2 companies from Faridan's portfolio have been acquired. The most recent acquisition was SolveBio in Jan 2023 by Quartz Bio for $*****.Here are Faridan's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 24, 2023 | - | - | 5018 | |
Apr 22, 2022 | - | - | 4098 |
Team profile of Faridan
Faridan has a team of 1 member located in United States. Faridan's team sits on the board of 1 company.Co-investors of Faridan
Over the past 9 years, 27 investors have co-invested in Faridan's portfolio companies. This includes funds and angels.
- Top Co-investors of Faridan: 3 investors entered a company along with Faridan. These include investors like Acks (1 company).
- Invested after Faridan: A total of 24 investors have invested in Faridan's portfolio after their investments. Top Investors include Temasek (1 company), TCG Crossover (1 company) and Arch Venture Partners (1 company).
